AskGene Pharma, Inc. is a U.S. based biotechnology firm located in Camarillo, California. AskGene’s mission is to develop and bring our patients biosimilar versions of leading global biopharmaceuticals and biosuperior molecules with validated targets. The firm was founded by a team of highly accomplished scientists from leading biotech organizations. Since then, AskGene has leveraged its scientific strengths and technical infrastructure to rapidly develop a few therapeutic molecules (monoclonal antibodies and fusion proteins), with its first IND approved within 7 months from its submission to CFDA and entering phase 1 clinical trial in 2017. AskGene is equipped with most advanced R&D facilities. Development is carried out with high standards of safety, efficacy and efficiency.